A personal blog entry about working through postdoctoral fellowships on antimicrobial peptides. Thin material with no new findings.
Recap by typeshit. Post by The Postdoctoral on X.
Avi Roy points out that the largest test so far found no memory benefit from the drug in Ozempic, despite hopes raised by health record studies.
Balwinder Singh and Raman Baweja link GLP-1 use to less kidney replacement therapy in bipolar patients with CKD, and flag lithium toxicity cases.
Yale Medicine says 5% to 10% of people on GLP-1 weight loss drugs see little result, and points to diet as one factor that can blunt the effect.
24:26
A doctor's explainer sorting peptides into eight broad categories. An evergreen overview for anyone still learning the basics.
AG Information Network of the West looks at GLP-1 users' effect on protein demand, alongside news on a US trade deal with Mexico.
A professor walks through peptides as short amino acid chains and their roles in cell signaling and regulation.
Loading…